SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt sells nutrition biz to Danone for Rs 1,576 cr

03 Aug 2011 Evaluate

Pharmaceutical major Wockhardt Ltd has agreed to sell its nutrition business to French food multinational Danone for about $356 million (Rs 1,576 crore), more than double the amount at which it had signed a similar deal with US pharmaceutical giant Abbott a year ago. The Abbott deal was called off after Wockhardt’s lenders opposed the sale of its nutrition business.

Under the current agreement, Danone will acquire Wockhardt's nutrition business and brands such as Farex, Dexolac, Nusobee and Protinex as well as related industrial operations from Carol Info Service, located in Punjab, to enter the baby nutrition and medical nutrition markets in India. Danone has global leadership in fresh dairy products and is the second largest player in bottled water and baby nutrition.

The renewal of negotiations became possible after the Bombay High Court refused to give an injunction to stall the sale of Wockhardt’s nutrition business as demanded by a section of the company's investors holding 40 per cent of its foreign currency convertible bonds last year. Wockhardt is yet to resolve its issues with its lenders, which include a clutch of investment firms and the company’s local competitor Sun Pharmaceuticals. The company may have to seek the Bombay High Court’s approval for the successful closure of the deal.crackcrack

Wockhardt Share Price

1396.80 37.70 (2.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×